Found 13 Fallopian Tube Cancer trials
A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
To assess safety and tolerability, including dose-limiting toxicities (DLTs), maximum tolerated dose (MTD), or maximum administered dose (MAD; if no MTD is defined) of IMGN151 when administered intravenouslyTo determine recommended Phase 2 dose (RP2D) for IMGN151To characterize the pharmacokinetics (PK) and immunogenicity of IMGN151 -To assess ORR for IMGN151 using …
This study investigates an investigational medication for women with advanced platinum-resistant epithelial ovarian cancer, including primary peritoneal and fallopian tube cancers. The purpose of this study is to evaluate the safety and effectiveness of the investigational medication in treating these types of cancers, which are known for being difficult to …
The purpose of this study is to assess the safety and effectiveness of a combination of investigational medication and another drug in treating advanced-stage ovarian, fallopian tube, or primary peritoneal cancer. This study targets cancers that express a specific protein called folate receptor alpha (FRα). This protein is found on …
This study aims to learn more about the use of Mirvetuximab soravtansine and Olaparib as a maintenance therapy after completion of prior therapy for recurrent platinum sensitive ovarian, peritoneal and fallopian tube cancer. Mirvetuximab soravtansine is an effective antibody drug conjugate that targets folate receptor alpha. Olaparib is one of …
Featured study
This study is divided into 2 parts (Escalation and Expansion). Your study doctor or study staff will also let you know you in what part of the study you will participate.The purpose of Part 1 (Escalation) of the study is to find the highest, safe dose of the study drug(s), …
This study investigates ovarian cancer. The purpose of this study is to compare the investigational medication, Sofetabart Mipitecan, with standard chemotherapy or other treatments for ovarian cancer.The study evaluates the effectiveness and safety of Sofetabart Mipitecan in treating ovarian cancer compared to current standard treatments.Who can participate: Participants must be …
Phase 2: To evaluate BICR-assessed objective response rate at each dose level of R-DXd. Phase 3:To evaluate BICR-assessed objective response rate with R-DXd treatment compared with investigator's choice of paclitaxel, PLD, gemcitabine, or topotecan. Objectives, outcome measures, and endpoints are located in Tables 3.1 and 3.2 of the protocol. Phase …
This study investigates how genetic testing can guide cancer treatment choices for patients with advanced solid tumors. The purpose is to use the genetic information from patients' tumor cells to match them with investigational combination therapies that target specific genetic mutations. This approach aims to control tumor growth and improve …
A Phase 2 study to evaluate the clinical activity, safety, and potentially predictive biomarker profile of ZN-c3 in subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
This study investigates an investigational medication designed to treat patients with advanced or metastatic solid tumors. The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of this medication both as a standalone treatment and in combination with other agents. The study is focused on …
1 - 10 of 13
- 1
- 2
Please choose between Voice or SMS based delivery of verification code
or